Skip to main content
EssilorLuxottica logo

EssilorLuxottica — Investor Relations & Filings

Ticker · EL ISIN · FR0014007HJ5 LEI · 549300M3VH1A3ER1TB49 PA Manufacturing
Open in API
Filings indexed 1,137 across all filing types
Latest filing 2025-02-12 Earnings Release
Country FR France
Listing PA EL

About EssilorLuxottica

https://www.essilorluxottica.com/

EssilorLuxottica is a global leader in the design, manufacture, and distribution of ophthalmic lenses, prescription frames, and sunglasses. The company operates a vertically integrated business model, managing a comprehensive portfolio of proprietary and licensed eyewear and vision care brands. Its activities encompass the production of advanced vision care products, including lenses and optical instruments, as well as a wide range of eyewear. EssilorLuxottica distributes its products through a global network of wholesale and retail channels, serving consumers with solutions for their vision needs and personal style.

Recent filings

Filing Released Lang Actions
EssilorLuxottica: Résultats T4 et annuels 2024 - Solide croissance du chiffre d’affaires et augmentation de la marge en 2024. Un nouveau vecteur de croissance : les lunettes connectées, débuts promett
Earnings Release Classification · 100% confidence The document text is titled "Résultats T4 et annuels 2024" (Q4 and Annual Results 2024) and contains detailed financial tables comparing 2024 results against 2023 results, including revenue, gross margin, operating income, and net income, both on an adjusted and unadjusted basis. It explicitly mentions that the consolidated accounts for the 2024 fiscal year have been finalized by the Board of Directors and that the audit report is being issued. This content structure—comprehensive annual financial performance review, management commentary on the full year, and detailed financial statements—is characteristic of a full Annual Report (10-K) or a very detailed Earnings Release/Interim Report. Since it covers the full fiscal year ('annuels 2024') and provides extensive financial breakdowns, it aligns best with the scope of an Annual Report, even if it is presented in a press release format summarizing the findings. Given the depth of the financial data provided (multiple tables covering revenue breakdown by activity and geography for the full year and Q4), it goes beyond a simple Earnings Release (ER) which usually provides only key highlights. It is more comprehensive than a typical Interim Report (IR) as it covers the full year. Therefore, it is classified as an Annual Report (10-K). Q4 2024
2025-02-12 French
EssilorLuxottica acquiert la start-up canadienne med-tech Cellview
M&A Activity Classification · 100% confidence The document is a press release announcing the acquisition of a company (Cellview Imaging) by EssilorLuxottica. This falls under M&A activity, which is categorized as 'TAR' (M&A Activity) in the provided schema.
2025-02-11 French
EssilorLuxottica acquires the Canadian med-tech start-up Cellview
M&A Activity Classification · 100% confidence The document is a press release announcing the acquisition of a Canadian med-tech start-up, Cellview Imaging, by EssilorLuxottica. This falls under M&A activity as it details a corporate acquisition, the strategic rationale, and management commentary regarding the transaction.
2025-02-11 English
EssilorLuxottica obtient l'autorisation de la FDA et les certifications européennes pour ses lunettes Nuance Audio qui seront désormais disponibles aux États-Unis et en Europe
Regulatory Filings Classification · 95% confidence The document is a press release announcing that EssilorLuxottica has received FDA and European regulatory approval for its 'Nuance Audio' glasses. It details the product's features, market availability, and strategic importance. It does not contain financial statements, audit results, or shareholder meeting materials. As it is a general corporate announcement regarding product development and regulatory milestones that does not fit into specific categories like M&A or dividends, it is classified as a general regulatory filing/announcement.
2025-02-03 French
EssilorLuxottica receives FDA clearance and EU certifications for Nuance Audio, making it available to consumers in the U.S. and Europe
Regulatory Filings Classification · 95% confidence The document is a press release announcing regulatory clearance (FDA and CE marking) for a new product, 'Nuance Audio'. It does not report financial results, dividends, or governance changes, nor is it a report publication announcement. As it is a general corporate announcement regarding product development and regulatory milestones that does not fit into specific categories like M&A or share issues, it falls under the general regulatory filing/announcement category.
2025-02-03 English
EssilorLuxottica: Full-Year 2024 Results Conference Call Invitation
Report Publication Announcement Classification · 95% confidence The document is an invitation to a conference call regarding the Full-Year 2024 results. It provides details on how to register for the call and access the webcast. It is not the financial report itself, but rather an announcement regarding the upcoming release of the report and the associated conference call. According to the 'Menu vs Meal' rule, this is a notification of a report/event, which fits the Report Publication Announcement (RPA) category.
2025-01-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.